Novavax Pharmaceuticals (NVAX. O) expanded premarket gains to more than 110 percent as the company reached a multi-billion dollar partnership with Sanofi.

Disclaimer:

1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.

2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.